Aspen Neuroscience Plans to Go Public
The San Diego biotech is developing a therapy to replace brain cells lost to Parkinson’s. The headline says it is going public.
The San Diego biotech is developing a therapy to replace brain cells lost to Parkinson’s. The headline says it is going public.